世界の子宮内膜症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Endometriosis Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2157 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、子宮内膜症治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン療法、アドバック薬、プロゲストーゲン、漢方薬）、用途別市場規模（病院、クリニック、研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・子宮内膜症治療薬の市場動向 ・企業の競争状況、市場シェア ・子宮内膜症治療薬の種類別市場規模（ホルモン療法、アドバック薬、プロゲストーゲン、漢方薬） ・子宮内膜症治療薬の用途別市場規模（病院、クリニック、研究所） ・子宮内膜症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・子宮内膜症治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・子宮内膜症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・子宮内膜症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・子宮内膜症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie、Astellas Pharma、AstraZeneca、Debiopharm Group、Evotec AG、Kissei Pharmaceutical、Neurocrine Biosciences、ObsEva、Pfizer、Repros Therapeutics、Roivant Sciences GmbH、Takeda Pharmaceutical Company Limited、ValiRx） ・結論

Endometriosis affects an estimated 1 in 10 women in the reproductive age group of 15-49 years.
Among these therapies, Elagolix, a first-in-class GnRH receptor antagonist, is closest to market.

Market Analysis and Insights: Global Endometriosis Drugs Market
The global Endometriosis Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Endometriosis Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Endometriosis Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Endometriosis Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Endometriosis Drugs market.

Global Endometriosis Drugs Scope and Market Size
Endometriosis Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Endometriosis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Hormonal Therapy
Add-back Medication
Progestogens
Chinese Herbs

Segment by Application
Hospitals
Clinics
Research Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Astellas Pharma
AstraZeneca
Debiopharm Group
Evotec AG
Kissei Pharmaceutical
Neurocrine Biosciences
ObsEva
Pfizer
Debiopharm Group
Evotec AG

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endometriosis Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hormonal Therapy
1.2.3 Add-back Medication
1.2.4 Progestogens
1.2.5 Chinese Herbs
1.3 Market by Application
1.3.1 Global Endometriosis Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Endometriosis Drugs Market Perspective (2016-2027)
2.2 Endometriosis Drugs Growth Trends by Regions
2.2.1 Endometriosis Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Endometriosis Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Endometriosis Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Endometriosis Drugs Industry Dynamic
2.3.1 Endometriosis Drugs Market Trends
2.3.2 Endometriosis Drugs Market Drivers
2.3.3 Endometriosis Drugs Market Challenges
2.3.4 Endometriosis Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Endometriosis Drugs Players by Revenue
3.1.1 Global Top Endometriosis Drugs Players by Revenue (2016-2021)
3.1.2 Global Endometriosis Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Endometriosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Endometriosis Drugs Revenue
3.4 Global Endometriosis Drugs Market Concentration Ratio
3.4.1 Global Endometriosis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endometriosis Drugs Revenue in 2020
3.5 Endometriosis Drugs Key Players Head office and Area Served
3.6 Key Players Endometriosis Drugs Product Solution and Service
3.7 Date of Enter into Endometriosis Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Endometriosis Drugs Breakdown Data by Type
4.1 Global Endometriosis Drugs Historic Market Size by Type (2016-2021)
4.2 Global Endometriosis Drugs Forecasted Market Size by Type (2022-2027)

5 Endometriosis Drugs Breakdown Data by Application
5.1 Global Endometriosis Drugs Historic Market Size by Application (2016-2021)
5.2 Global Endometriosis Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Endometriosis Drugs Market Size (2016-2027)
6.2 North America Endometriosis Drugs Market Size by Type
6.2.1 North America Endometriosis Drugs Market Size by Type (2016-2021)
6.2.2 North America Endometriosis Drugs Market Size by Type (2022-2027)
6.2.3 North America Endometriosis Drugs Market Size by Type (2016-2027)
6.3 North America Endometriosis Drugs Market Size by Application
6.3.1 North America Endometriosis Drugs Market Size by Application (2016-2021)
6.3.2 North America Endometriosis Drugs Market Size by Application (2022-2027)
6.3.3 North America Endometriosis Drugs Market Size by Application (2016-2027)
6.4 North America Endometriosis Drugs Market Size by Country
6.4.1 North America Endometriosis Drugs Market Size by Country (2016-2021)
6.4.2 North America Endometriosis Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Endometriosis Drugs Market Size (2016-2027)
7.2 Europe Endometriosis Drugs Market Size by Type
7.2.1 Europe Endometriosis Drugs Market Size by Type (2016-2021)
7.2.2 Europe Endometriosis Drugs Market Size by Type (2022-2027)
7.2.3 Europe Endometriosis Drugs Market Size by Type (2016-2027)
7.3 Europe Endometriosis Drugs Market Size by Application
7.3.1 Europe Endometriosis Drugs Market Size by Application (2016-2021)
7.3.2 Europe Endometriosis Drugs Market Size by Application (2022-2027)
7.3.3 Europe Endometriosis Drugs Market Size by Application (2016-2027)
7.4 Europe Endometriosis Drugs Market Size by Country
7.4.1 Europe Endometriosis Drugs Market Size by Country (2016-2021)
7.4.2 Europe Endometriosis Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Endometriosis Drugs Market Size (2016-2027)
8.2 Asia-Pacific Endometriosis Drugs Market Size by Type
8.2.1 Asia-Pacific Endometriosis Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Endometriosis Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Endometriosis Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Endometriosis Drugs Market Size by Application
8.3.1 Asia-Pacific Endometriosis Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Endometriosis Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Endometriosis Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Endometriosis Drugs Market Size by Region
8.4.1 Asia-Pacific Endometriosis Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Endometriosis Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Endometriosis Drugs Market Size (2016-2027)
9.2 Latin America Endometriosis Drugs Market Size by Type
9.2.1 Latin America Endometriosis Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Endometriosis Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Endometriosis Drugs Market Size by Type (2016-2027)
9.3 Latin America Endometriosis Drugs Market Size by Application
9.3.1 Latin America Endometriosis Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Endometriosis Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Endometriosis Drugs Market Size by Application (2016-2027)
9.4 Latin America Endometriosis Drugs Market Size by Country
9.4.1 Latin America Endometriosis Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Endometriosis Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Endometriosis Drugs Market Size (2016-2027)
10.2 Middle East & Africa Endometriosis Drugs Market Size by Type
10.2.1 Middle East & Africa Endometriosis Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Endometriosis Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Endometriosis Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Endometriosis Drugs Market Size by Application
10.3.1 Middle East & Africa Endometriosis Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Endometriosis Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Endometriosis Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Endometriosis Drugs Market Size by Country
10.4.1 Middle East & Africa Endometriosis Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Endometriosis Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Endometriosis Drugs Introduction
11.1.4 AbbVie Revenue in Endometriosis Drugs Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Details
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Endometriosis Drugs Introduction
11.2.4 Astellas Pharma Revenue in Endometriosis Drugs Business (2016-2021)
11.2.5 Astellas Pharma Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Endometriosis Drugs Introduction
11.3.4 AstraZeneca Revenue in Endometriosis Drugs Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Debiopharm Group
11.4.1 Debiopharm Group Company Details
11.4.2 Debiopharm Group Business Overview
11.4.3 Debiopharm Group Endometriosis Drugs Introduction
11.4.4 Debiopharm Group Revenue in Endometriosis Drugs Business (2016-2021)
11.4.5 Debiopharm Group Recent Development
11.5 Evotec AG
11.5.1 Evotec AG Company Details
11.5.2 Evotec AG Business Overview
11.5.3 Evotec AG Endometriosis Drugs Introduction
11.5.4 Evotec AG Revenue in Endometriosis Drugs Business (2016-2021)
11.5.5 Evotec AG Recent Development
11.6 Kissei Pharmaceutical
11.6.1 Kissei Pharmaceutical Company Details
11.6.2 Kissei Pharmaceutical Business Overview
11.6.3 Kissei Pharmaceutical Endometriosis Drugs Introduction
11.6.4 Kissei Pharmaceutical Revenue in Endometriosis Drugs Business (2016-2021)
11.6.5 Kissei Pharmaceutical Recent Development
11.7 Neurocrine Biosciences
11.7.1 Neurocrine Biosciences Company Details
11.7.2 Neurocrine Biosciences Business Overview
11.7.3 Neurocrine Biosciences Endometriosis Drugs Introduction
11.7.4 Neurocrine Biosciences Revenue in Endometriosis Drugs Business (2016-2021)
11.7.5 Neurocrine Biosciences Recent Development
11.8 ObsEva
11.8.1 ObsEva Company Details
11.8.2 ObsEva Business Overview
11.8.3 ObsEva Endometriosis Drugs Introduction
11.8.4 ObsEva Revenue in Endometriosis Drugs Business (2016-2021)
11.8.5 ObsEva Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Endometriosis Drugs Introduction
11.9.4 Pfizer Revenue in Endometriosis Drugs Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Repros Therapeutics
11.10.1 Repros Therapeutics Company Details
11.10.2 Repros Therapeutics Business Overview
11.10.3 Repros Therapeutics Endometriosis Drugs Introduction
11.10.4 Repros Therapeutics Revenue in Endometriosis Drugs Business (2016-2021)
11.10.5 Repros Therapeutics Recent Development
11.11 Roivant Sciences GmbH
11.11.1 Roivant Sciences GmbH Company Details
11.11.2 Roivant Sciences GmbH Business Overview
11.11.3 Roivant Sciences GmbH Endometriosis Drugs Introduction
11.11.4 Roivant Sciences GmbH Revenue in Endometriosis Drugs Business (2016-2021)
11.11.5 Roivant Sciences GmbH Recent Development
11.12 Takeda Pharmaceutical Company Limited
11.12.1 Takeda Pharmaceutical Company Limited Company Details
11.12.2 Takeda Pharmaceutical Company Limited Business Overview
11.12.3 Takeda Pharmaceutical Company Limited Endometriosis Drugs Introduction
11.12.4 Takeda Pharmaceutical Company Limited Revenue in Endometriosis Drugs Business (2016-2021)
11.12.5 Takeda Pharmaceutical Company Limited Recent Development
11.13 ValiRx
11.13.1 ValiRx Company Details
11.13.2 ValiRx Business Overview
11.13.3 ValiRx Endometriosis Drugs Introduction
11.13.4 ValiRx Revenue in Endometriosis Drugs Business (2016-2021)
11.13.5 ValiRx Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Endometriosis Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hormonal Therapy
Table 3. Key Players of Add-back Medication
Table 4. Key Players of Progestogens
Table 5. Key Players of Chinese Herbs
Table 6. Global Endometriosis Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Endometriosis Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Endometriosis Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Endometriosis Drugs Market Share by Regions (2016-2021)
Table 10. Global Endometriosis Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Endometriosis Drugs Market Share by Regions (2022-2027)
Table 12. Endometriosis Drugs Market Trends
Table 13. Endometriosis Drugs Market Drivers
Table 14. Endometriosis Drugs Market Challenges
Table 15. Endometriosis Drugs Market Restraints
Table 16. Global Endometriosis Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Endometriosis Drugs Market Share by Players (2016-2021)
Table 18. Global Top Endometriosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometriosis Drugs as of 2020)
Table 19. Ranking of Global Top Endometriosis Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Endometriosis Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Endometriosis Drugs Product Solution and Service
Table 23. Date of Enter into Endometriosis Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Endometriosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Endometriosis Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Endometriosis Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Endometriosis Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Endometriosis Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Endometriosis Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global Endometriosis Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Endometriosis Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Endometriosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Endometriosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Endometriosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Endometriosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Endometriosis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Endometriosis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Endometriosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Endometriosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Endometriosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Endometriosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Endometriosis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Endometriosis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Endometriosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Endometriosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Endometriosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Endometriosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Endometriosis Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Endometriosis Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Endometriosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Endometriosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Endometriosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Endometriosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Endometriosis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Endometriosis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Endometriosis Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Endometriosis Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Endometriosis Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Endometriosis Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Endometriosis Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Endometriosis Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. AbbVie Company Details
Table 64. AbbVie Business Overview
Table 65. AbbVie Endometriosis Drugs Product
Table 66. AbbVie Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 67. AbbVie Recent Development
Table 68. Astellas Pharma Company Details
Table 69. Astellas Pharma Business Overview
Table 70. Astellas Pharma Endometriosis Drugs Product
Table 71. Astellas Pharma Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 72. Astellas Pharma Recent Development
Table 73. AstraZeneca Company Details
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Endometriosis Drugs Product
Table 76. AstraZeneca Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 77. AstraZeneca Recent Development
Table 78. Debiopharm Group Company Details
Table 79. Debiopharm Group Business Overview
Table 80. Debiopharm Group Endometriosis Drugs Product
Table 81. Debiopharm Group Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 82. Debiopharm Group Recent Development
Table 83. Evotec AG Company Details
Table 84. Evotec AG Business Overview
Table 85. Evotec AG Endometriosis Drugs Product
Table 86. Evotec AG Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 87. Evotec AG Recent Development
Table 88. Kissei Pharmaceutical Company Details
Table 89. Kissei Pharmaceutical Business Overview
Table 90. Kissei Pharmaceutical Endometriosis Drugs Product
Table 91. Kissei Pharmaceutical Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 92. Kissei Pharmaceutical Recent Development
Table 93. Neurocrine Biosciences Company Details
Table 94. Neurocrine Biosciences Business Overview
Table 95. Neurocrine Biosciences Endometriosis Drugs Product
Table 96. Neurocrine Biosciences Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 97. Neurocrine Biosciences Recent Development
Table 98. ObsEva Company Details
Table 99. ObsEva Business Overview
Table 100. ObsEva Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 101. ObsEva Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Endometriosis Drugs Product
Table 105. Pfizer Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 106. Pfizer Recent Development
Table 107. Repros Therapeutics Company Details
Table 108. Repros Therapeutics Business Overview
Table 109. Repros Therapeutics Endometriosis Drugs Product
Table 110. Repros Therapeutics Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 111. Repros Therapeutics Recent Development
Table 112. Roivant Sciences GmbH Company Details
Table 113. Roivant Sciences GmbH Business Overview
Table 114. Roivant Sciences GmbH Endometriosis Drugs Product
Table 115. Roivant Sciences GmbH Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 116. Roivant Sciences GmbH Recent Development
Table 117. Takeda Pharmaceutical Company Limited Company Details
Table 118. Takeda Pharmaceutical Company Limited Business Overview
Table 119. Takeda Pharmaceutical Company Limited Endometriosis Drugs Product
Table 120. Takeda Pharmaceutical Company Limited Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 121. Takeda Pharmaceutical Company Limited Recent Development
Table 122. ValiRx Company Details
Table 123. ValiRx Business Overview
Table 124. ValiRx Endometriosis Drugs Product
Table 125. ValiRx Revenue in Endometriosis Drugs Business (2016-2021) & (US$ Million)
Table 126. ValiRx Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endometriosis Drugs Market Share by Type: 2020 VS 2027
Figure 2. Hormonal Therapy Features
Figure 3. Add-back Medication Features
Figure 4. Progestogens Features
Figure 5. Chinese Herbs Features
Figure 6. Global Endometriosis Drugs Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Research Institutes Case Studies
Figure 10. Endometriosis Drugs Report Years Considered
Figure 11. Global Endometriosis Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Endometriosis Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Endometriosis Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Endometriosis Drugs Market Share by Regions (2022-2027)
Figure 15. Global Endometriosis Drugs Market Share by Players in 2020
Figure 16. Global Top Endometriosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometriosis Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Endometriosis Drugs Revenue in 2020
Figure 18. Global Endometriosis Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Endometriosis Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Endometriosis Drugs Market Share by Type (2016-2027)
Figure 22. North America Endometriosis Drugs Market Share by Application (2016-2027)
Figure 23. North America Endometriosis Drugs Market Share by Country (2016-2027)
Figure 24. United States Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Endometriosis Drugs Market Share by Type (2016-2027)
Figure 28. Europe Endometriosis Drugs Market Share by Application (2016-2027)
Figure 29. Europe Endometriosis Drugs Market Share by Country (2016-2027)
Figure 30. Germany Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Endometriosis Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Endometriosis Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Endometriosis Drugs Market Share by Region (2016-2027)
Figure 40. China Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Endometriosis Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Endometriosis Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Endometriosis Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Endometriosis Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Endometriosis Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Endometriosis Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Endometriosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AbbVie Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 60. Astellas Pharma Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 61. AstraZeneca Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 62. Debiopharm Group Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 63. Evotec AG Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 64. Kissei Pharmaceutical Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 65. Neurocrine Biosciences Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 66. ObsEva Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 67. Pfizer Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 68. Repros Therapeutics Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 69. Roivant Sciences GmbH Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 70. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 71. ValiRx Revenue Growth Rate in Endometriosis Drugs Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---